Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2009
11/05/2009US20090275142 Compositions and methods for biodetection by nucleic acid-templated chemistry
11/04/2009EP2113502A1 Hydrazyde type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
11/04/2009EP2112992A1 A process for the preparation of -2-n [(s)-1-ethoxycarbonyl-3-phenylpropyl]-(s)-alanyl]-(1s, 3s, 5s)-2-azabicyclo [3.3.0] octane-3-carboxylic acid
11/04/2009EP1444739B1 Light emitting device and compounds for use therein
11/04/2009EP1216226B1 Process for phenylacetic acid derivatives
11/04/2009CN101573333A Inhibitors of histone deacetylase
11/03/2009US7612214 Organic amine salts of glutamic acid derivatives and their application
11/03/2009US7612213 (E)-ethyl 7-hydroxy-2-methyl-2-heptenate; (3E, 5E)-tert-butyl-9-(tert-butyldimethylsiloxy)-2-[(E)-ethylid ene]-4-methylnona-3,5-dienate
11/03/2009US7612099 Such as 3-[(5-Fluoro-3-methyl-1H-indol-2-yl)-phenyl-methyl]-4-hydroxy-5-isopropyl-1,5-dihydro-pyrrol-2-one which inhibits chymase
11/03/2009US7612089 N-[4-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenyl]-2N-(4-chlorophenylaminocarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide; thrombosis; inhibits coagulation of a blood sample
11/03/2009US7612065 Fused n-heterocylic derivatives; mitogen-activated protein kinase inhibitors; Parkinson's disease
11/03/2009US7612036 Such as methyl (2S,5S,8R/S)-8-acetamido-2-allyl-9-[6-allyl-9-tert-butoxycarbonyl-9H-carbazol-3-yl]-3,6-diaza-5-{3-[(2,2,5,7,8-pentamethylchroman-6-sulfonyl)-guanidino]propyl}-4,7-dioxononanoate; for treatment of bacterial infections, such as those caused by vancomycin resistant microorganisms
11/03/2009US7611880 Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors
11/03/2009CA2497074C Substituted spirocyclic ketoenols
11/03/2009CA2420585C Amides of r-2-(aminoaryl)-propionic acids for use in the prevention of leucocyte activation
10/2009
10/29/2009WO2009131657A1 Asymmetric alpha functionalization and alpha, alpha bisfunctionalization of aldehydes and ketones
10/29/2009WO2009131199A1 Anthracene derivative, light-emitting element, light-emitting device, and electronic appliance
10/29/2009WO2009131189A1 Ketoxime ester compound and use thereof
10/29/2009WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009035951A3 Soluble epoxide hydrolase inhibitors
10/29/2009WO2008106334A3 Flame retarded styrenic polymer foams and foam precursors
10/29/2009US20090270637 such as (7S)-7-methyl-4-oxo-5-[(1R)-phenylethyl]-5-azaspiro[2.4]heptane-7-carboxylate ester; intermediate for quinolonecarboxylic acid antibacterial agents; pharmacokinetics
10/29/2009US20090270477 Polymorphs of a hydroisoindoline tachykinin receptor antagonist
10/29/2009US20090270446 Diamine derivatives
10/29/2009US20090270414 2,3,4,9- tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
10/29/2009US20090270408 Amide derivatives as positive allosteric modulators and methods of use thereof
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090269408 Aqueous formulations of imidoalkanepercarboxylic acids
10/29/2009US20090267498 Anthracene Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Appliance
10/29/2009CA2722258A1 N-acylthiourea and n-acylurea inhibitors of the hedgehog protein signalling pathway
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/28/2009EP2112227A1 Aldolases, nucleic acids encoding them and methods for making and using them
10/28/2009CN101565472A Ketoxime ester photoinitiator
10/28/2009CN101565396A Technique for refining L-tryptophan
10/28/2009CN101565395A Technique for extracting L-tryptophan in fermentation liquor
10/28/2009CN101565393A 3-(substituted bisulfonyl fluromethane)-1-propylene compound, synthetic method and applications thereof
10/28/2009CN101565378A Preparation of derivative of dibenzoyl methane and application thereof
10/28/2009CN100554252C Method for preparing Sumatriptan Succinate
10/27/2009US7608731 Phenylacetic acid compounds
10/27/2009US7608723 Indole and benzimidazole derivatives
10/27/2009US7608711 Reduction with sodium borohydride; lower content of chloroketone and impurity in final product
10/27/2009US7608633 1-(4-Octylphenoxy)-3-(pyrrol-1-yl)propan-2-one, for example; for preventing and treating diseases caused by an increased activity of this enzyme, such as inflammation, pain, fever, allergies, asthma, psoriasis and endotoxic shock
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608617 N,N-alkylene-6-(piperidin-1-ylalkoxy)naphthalene-2-carboxamide derivatives, e.g., piperidin-1-yl-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone and 3,4-dihydro-1H-isoquinolin-2-yl)-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone; especially for treating obesity
10/27/2009US7608248 phenylalanine and tyrosin having a labeled pattern ( deuteration) which allows the chain-assignment of the signals originated from the main chain to extend even to the assignment of the ring portions; when determining protein structure by nuclear magnetic resonance, permits improvment in the sensitivity
10/27/2009US7608244 benz[e]indole derivatives that absorb and fluoresce in the visible region of light, particularly useful for optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo; low molecular weight compounds; non-immunogenic
10/27/2009CA2465534C Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
10/27/2009CA2435426C Process for the preparation of (3-cyano-1h-indol-7-yl)(4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof
10/27/2009CA2415050C Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo[2,1-b][1,3]benzothiazepines
10/27/2009CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/27/2009CA2379021C New phenylpiperazines
10/27/2009CA2341434C Pyrrolobenzodiazepine compounds
10/27/2009CA2318976C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
10/27/2009CA2318145C Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
10/22/2009WO2009127686A1 Novel estrogen receptor ligands
10/22/2009WO2009127338A1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/22/2009US20090264656 Method for manufacture of sertindole
10/22/2009US20090264655 Intermediates to HCV inhibitors; One pot borylation/Suzuki coupling process
10/22/2009US20090264653 Useful indole compounds
10/22/2009US20090264494 Use of neuroprotective 3-substituted indolone compositions
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264414 Amide Derivatives and Pharmaceutical Use Thereof
10/22/2009US20090263353 Novel Sulphonylpyrroles as Inhibitors of Hdac S Novel Sulphonylpyrroles
10/22/2009US20090263327 Minimally invasive physiological function monitoring agents
10/22/2009US20090261717 Novel materials for organic electroluminescent devices
10/22/2009CA2720215A1 Novel estrogen receptor ligands
10/21/2009EP2110369A1 Method of synthesizing 9-aryl-10-iodoanthracene derivative and light-emitting material
10/21/2009EP1781608B1 Indole derivatives comprising an acetylene group as ppar activators
10/21/2009EP1708997B1 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions
10/21/2009EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
10/21/2009EP1395615B1 Oxime ester photoinitiators having a combined structure
10/21/2009EP1381366B9 Indole, azaindole and related heterocyclic amidopiperazine derivatives
10/21/2009CN101563322A 1H-indole-2-carboxylic acid derivatives useful as PPAR modulators
10/21/2009CN101563321A 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands
10/21/2009CN101563320A [2-(6-flouro-1H-indol-3-ylsulfanyl)benzyl]methyl amine for the treatment of affective disorders
10/21/2009CN101562232A Color-adjustable organic electroluminescent device and preparation method thereof
10/21/2009CN101560180A Method for preparing 4-halo-isoindoline hydrochloride
10/21/2009CN101560179A Azotic indole derivative with H3 receptor affinity and applications
10/21/2009CN101560178A Polysubstituted indoline compound, preparation method and medical application thereof
10/21/2009CN101560154A 6,6,6-trifluoromethyl-5-carbonyl methyl hexanoate, 2-trifluoromethyl-3-methyl indole propionate and synthesis method thereof
10/21/2009CN101560153A 7,7,7-trifluoromethyl-6-carbonyl methyl heptanoate, 5-fluoro-2-trifluoromethyl-3-methyl indole butyrate and synthesis method thereof
10/21/2009CN101560136A Novel organic electroluminescent compounds and organic electroluminescent device using the same
10/21/2009CN101560132A Method for racemizing chiral amino acid or derivatives of chiral amino acid
10/21/2009CN100551907C Compound in category of aryl methylamino dithio formic ether, preparation method and application
10/20/2009US7606771 Dynamic number authentication for credit/debit cards
10/20/2009US7605274 precipitating crystalline form from solvent solution using water as an antisolvent
10/20/2009US7605176 β-ketoamide compounds with MCH antagonistic activity
10/20/2009US7605162 Indole-3-alkyl-N-piperazine ring substituted with quinoline ring or derivatives; high affinity for both the dopamine D2 receptor and the serotonin reuptake site; nervous system disorders, such as anxiety disorders, depression, Parkinson's disease, and schizophrenia
10/20/2009US7605111 Herbicides
10/20/2009CA2434408C Process for the preparation of heterocyclic indene analogs
10/20/2009CA2378183C Antibacterial heterobicyclic substituted phenyl oxazolidinones
10/15/2009WO2009125853A1 Homocysteine synthase inhibitor
10/15/2009WO2009125851A1 Method for detection of effectiveness of phenylalanine derivative-type compound in diabetes patient
10/15/2009WO2009125230A1 Pharmaceutical compounds
10/15/2009WO2009124692A1 New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors.
10/15/2009WO2009124627A1 Fluorine derivatives for organic electroluminescence devices
10/15/2009US20090259052 Processes of producing glutamic acid compounds and production intermediates therefore and novel intermediate for the processes
10/15/2009US20090259051 Carvedilol phosphate sesquihydrate
1 ... 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 ... 458